-
Cable Raw Materials (PVC) Weekly Report (7.10-7.14
Time of Update: 2022-12-06
First, the upstream market dynamics of cable raw materials (PVC). 1. Cable raw materials (PVC) upstream market dynamic cable raw materials (PVC)This week, the domestic calcium carbide market rose. Th
-
The research and development of new Chinese medicines is still accelerating, and another class 1 new drug is applied for clinical trials
Time of Update: 2022-08-20
The clinical application of Tongjiang Granules is the company's second class 1 new drug in the Chinese patent medicine stomach medicine market, which is mainly used for the treatment of gastroesophageal reflux disease .
-
The world's first
Time of Update: 2022-06-13
April 17, 2022/eMedClub News/--On March 31, 2022, the clinical trial application of the innovative drug ARB202 developed by ARBELE, a biotechnology company in Hong Kong Science Park, was approved by the Australian TGA.
-
[Heavyweight] The first domestically produced Class 1 new anti-ED drug, AIRIS®, is on the market, and Yuekang Pharmaceutical has stepped up its innovation and upgrade
Time of Update: 2022-01-09
New product launches and multi-channel simultaneous efforts As a domestic patented new anti-ED drug, AIRIS® Aldenafil Citrate Tablets has the advantages of good patient experience, high safety, and low side effects compared with similar products on the market .
-
Epichlorohydrin daily review: wait and see after the holiday
Time of Update: 2021-04-24
Once the starting load increases and the market supply eases the contradiction, the epichlorohydrin market is expected Stepping into downward adjustment; the opening atmosphere is light, trading companies rarely offer active quotations, it is heard that mainstream manufacturers still have upward adjustment intentions, pending certification, most downstream industries have not yet returned to the market, and the reference negotiation level is temporarily maintained; currently there is still a trend of low prices.
